Rani Asha, Ranjan Ravi, McGee Halvor S, Andropolis Kalista E, Panchal Dipti V, Hajjiri Zahraa, Brennan Daniel C, Finn Patricia W, Perkins David L
Department of Medicine, University of Illinois, Chicago, Ill.
Division of Renal Diseases, Washington University School of Medicine, St. Louis, Mo.
Transl Res. 2017 Mar;181:59-70. doi: 10.1016/j.trsl.2016.08.008. Epub 2016 Sep 9.
Recent studies have established that a complex community of microbes colonize the human urinary tract; however, their role in kidney transplant patients treated with prophylactic antibiotics remains poorly investigated. Our aim was to investigate the urinary microbiome of kidney transplant recipients. Urine samples from 21 patients after kidney transplantation and 8 healthy controls were collected. All patients received prophylactic treatment with the antibiotic combination trimethoprim-sulfamethoxazole. Metagenomic DNA was isolated from urine samples, sequenced using shotgun sequencing approach on Illumina HiSeq 2000 platform, and analyzed for microbial taxonomic and functional annotations. Our results demonstrate that the urine microbiome of kidney transplants was markedly different at all taxonomic levels from phyla to species, had decreased microbial diversity, and increased abundance of potentially pathogenic species compared with healthy controls. Specifically, at the phylum level, we detected a significant decrease in Actinobacteria and increase in Firmicutes due to increases in Enterococcus faecalis. In addition, there was an increase in the Proteobacteria due to increases in Escherichia coli. Analysis of predicted functions of the urinary metagenome revealed increased abundance of enzymes in the folate pathway including dihydrofolate synthase that are not inhibited by trimethoprim-sulfamethoxazole, but can augment folate metabolism. This report characterizes the urinary microbiome of kidney transplants using shotgun metagenomics approach. Our results indicate that the urinary microbiota may be modified in the context of prophylactic antibiotics, indicating that a therapeutic intervention may shift the urinary microbiota to select bacterial species with increased resistance to antibiotics. The evaluation and development of optimal prophylactic regimens that do not promote antibiotic resistance is an important future goal.
近期研究证实,人类尿道中定殖着复杂的微生物群落;然而,它们在接受预防性抗生素治疗的肾移植患者中所起的作用仍未得到充分研究。我们的目的是调查肾移植受者的尿液微生物组。收集了21例肾移植术后患者及8名健康对照者的尿液样本。所有患者均接受了甲氧苄啶 - 磺胺甲恶唑联合抗生素的预防性治疗。从尿液样本中分离出宏基因组DNA,在Illumina HiSeq 2000平台上采用鸟枪法测序进行测序,并对微生物进行分类学和功能注释分析。我们的结果表明,与健康对照相比,肾移植患者的尿液微生物组在从门到种的所有分类水平上均有显著差异,微生物多样性降低,潜在致病物种的丰度增加。具体而言,在门水平上,由于粪肠球菌增加,我们检测到放线菌显著减少,厚壁菌门增加。此外,由于大肠杆菌增加,变形菌门也有所增加。对尿液宏基因组预测功能的分析显示,叶酸途径中的酶丰度增加,包括不受甲氧苄啶 - 磺胺甲恶唑抑制但可增强叶酸代谢的二氢叶酸合酶。本报告采用鸟枪法宏基因组学方法对肾移植患者的尿液微生物组进行了表征。我们的结果表明,在预防性使用抗生素的情况下,尿液微生物群可能会发生改变,这表明治疗干预可能会使尿液微生物群转向选择对抗生素耐药性增加的细菌物种。评估和制定不促进抗生素耐药性的最佳预防方案是未来的一个重要目标。